PATENT CLAIM ANALYSIS

Application Number: 15866744
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "180000"]

Abstract:
The present invention aims to provide an eye drop for treating macular edema. The present invention provides an eye drop for treating macular edema, which contains difluprednate as an active ingredient. The eye drop can afford effects such as improvement of visual acuity and decreased foveal retinal thickness in macular edema.

Claim (Index 55):
A method of improving the visual acuity in a mammal with macular edema comprising instilling an emulsion eye drop containing an effective amount of difluprednate to an eye of the mammal, wherein the concentration of difluprednate in the eye drop is 0.05% (w/v).

Metadata:
- Claim Count in Document: 41.0
- Percentile: 86.0
- Lexical Diversity: 1.52778
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14661295', '13940370', '15471506', '11695527', '14972560']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7539952383217465
- 35 USC 102 Novelty (BERT): 0.6543860887815242
- Combined Prediction Score: 0.7440343233677243
- Mean Citation Score: 323.74317600000006
- Max Citation Score: 652.79486
- Similarity Product: 603.2821532363058

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test